Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles (Q39005101)

8 September 2017

1 reference

title

Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles (English)

1 reference

8 September 2017

1 reference

1 reference

Min Li

1

1 reference

8 September 2017

Peng Zou

series ordinal

2

1 reference

8 September 2017

Katherine Tyner

series ordinal

3

1 reference

8 September 2017

Sau Lee

series ordinal

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

10 November 2016

1 reference

8 September 2017

1 reference

8 September 2017

19

1 reference

8 September 2017

26-42

1 reference

8 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1208/s12248-016-0010-3

8 September 2017

0 references

cites work

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

1 reference

12 December 2020

Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats

1 reference

12 December 2020

Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies

1 reference

12 December 2020

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles

1 reference

12 December 2020

Determination of plasma protein adsorption on magnetic iron oxides: sample preparation

1 reference

12 December 2020

Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model

1 reference

12 December 2020

Convective diffusion of nanoparticles from the epithelial barrier toward regional lymph nodes

1 reference

12 December 2020

Physiologically based pharmacokinetics of molecular imaging nanoparticles for mRNA detection determined in tumor-bearing mice.

1 reference

12 December 2020

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

1 reference

12 December 2020

Extraction and analysis of silver and gold nanoparticles from biological tissues using single particle inductively coupled plasma mass spectrometry

1 reference

12 December 2020

Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles

1 reference

12 December 2020

A Tutorial on Target-Mediated Drug Disposition (TMDD) Models

1 reference

12 December 2020

Principles of nanoparticle design for overcoming biological barriers to drug delivery

1 reference

12 December 2020

Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments

1 reference

12 December 2020

Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.

1 reference

12 December 2020

Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection

1 reference

12 December 2020

Pharmacologic target-mediated drug disposition

1 reference

12 December 2020

Drug nanocrystals in the commercial pharmaceutical development process

1 reference

12 December 2020

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

1 reference

12 December 2020

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients.

1 reference

12 December 2020

Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease

1 reference

12 December 2020

Protracted elimination of gold nanoparticles from mouse liver

1 reference

12 December 2020

Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models

1 reference

12 December 2020

Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling

1 reference

12 December 2020

Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review

1 reference

12 December 2020

Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology

1 reference

12 December 2020

In vivo biodistribution of nanoparticles

1 reference

12 December 2020

Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors

1 reference

12 December 2020

Development of a physiologically based kinetic model for 99m-technetium-labelled carbon nanoparticles inhaled by humans

1 reference

12 December 2020

Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content

1 reference

12 December 2020

Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat.

1 reference

12 December 2020

Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats

1 reference

12 December 2020

Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation

1 reference

12 December 2020

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

1 reference

12 December 2020

Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition

1 reference

12 December 2020

Renal clearance of quantum dots

1 reference

12 December 2020

Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions

1 reference

12 December 2020

Biodistribution of 1.4- and 18-nm gold particles in rats

1 reference

12 December 2020

Physiologically Based Pharmacokinetic Modeling of Fluorescently Labeled Block Copolymer Nanoparticles for Controlled Drug Delivery in Leukemia Therapy

1 reference

12 December 2020

Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition.

1 reference

12 December 2020

An imaging-driven model for liposomal stability and circulation

1 reference

12 December 2020

A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles

1 reference

12 December 2020

Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

1 reference

12 December 2020

The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior

1 reference

12 December 2020

The kinetics of the tissue distribution of silver nanoparticles of different sizes.

1 reference

12 December 2020

Doxorubicin loaded pH-responsive micelles capable of rapid intracellular drug release for potential tumor therapy

1 reference

12 December 2020

Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma

1 reference

12 December 2020

Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?

1 reference

12 December 2020

Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV.

1 reference

12 December 2020

Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.

1 reference

12 December 2020

Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats

1 reference

12 December 2020

Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice.

1 reference

12 December 2020

Protein-nanoparticle interactions: opportunities and challenges

1 reference

12 December 2020

An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin

1 reference

12 December 2020

Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling of nanoparticles

1 reference

12 December 2020

Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.

1 reference

12 December 2020

A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs

1 reference

12 December 2020

A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles

1 reference

12 December 2020

A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice

1 reference

12 December 2020

10.1208/S12248-016-0010-3

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

0 references

1 reference